Its cash, cash equivalents, and short-term marketable securities balance was around $1.2 billion in 2022, and we expect the trend of no/low debt and deep pockets of cash to continue over the next five ...

A new year means new laws that have gone into effect here in Illinois. Governor J.B. Pritzker said that "For thousands of Illinoisans, the reforms in this bill will mean the difference between ...

The U.S. Food and Drug Administration has approved a new non-opioid pain medication developed by Boston-based Vertex ...

To understand how the Mayo Clinic became a superior healthcare brand, I talked with Leonard Berry, PhD, to understand their ...

The convenience store segment faced economic challenges in 2024 with shifting consumer preferences, consolidation, inflation ...

Recalls on a brand of broccoli and chocolate from December were recently upgraded to Class I, the highest risk level issued ...

The U.S. Food and Drug Administration has approved a novel prescription pain medication that targets sodium channels involved ...

The new FDA-approved pain drug is suzetrigine, with the brand name Journavx. Suzetrigine is designed to alleviate moderate to ...

President Donald Trump's steep tariffs on Canada, Mexico and China could worsen exist­ing drug short­ages in the U.S. and ...

The FDA defines a Class 1 recall as “a situation in which there is a reasonable probability that the use of or exposure to a ...

There is growing momentum to legalize certain psychedelics — namely psilocybin. That push is well underway in Nevada.